Novel benzofuranoxyethylamines of the formula (1), in which R
1
, R
2
, R
3
, R
4
, m and n have the meanings indicated in Patent Claim (
1
), which have a strong affinity to the 5 HT
1A
receptors and/or 5HT
1D
receptors. The compounds inhibit serotonin reuptake, exhibit serotonin-agonistic and -antagonistic properties and are suitable as antidepressants, anxiolytics, antipsychotics, neuroleptics and/or antihypertonics.
式 (1) 的新型
苯并呋喃氧乙胺,其中 R
1
, R
2
, R
3
, R
4
m 和 n 具有专利权利要求 (
1
),它们与 5 HT
1A
受体和/或 5HT
1D
受体有很强的亲和力。这些化合物可抑制
血清素再摄取,具有
血清素拮抗和拮抗特性,适合用作抗抑郁药、
抗焦虑药、
抗精神病药、神经
安定药和/或
抗变态反应药。